Aurora Cannabis Stock Price Target and Analyst Ratings (NYSE:ACB)

Analyst Price Target for ACB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$10.93

▲ +42.83% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is $10.93, with a high forecast of $18.00 and a low forecast of $3.60. The average price target represents a 42.83% upside from the last price of $7.65.

The #1 Way to Play the CBD Sector

From Investing Trends

A proprietary product line, unmatched distribution formula, and exponential growth potential in an explosive industry makes this company the top way to play the legal cannabis sector

Hold

The current consensus among 15 polled investment analysts is to hold stock in Aurora Cannabis. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
1 buy ratings
7 hold ratings
6 sell ratings

Ratings as of

10/29/2019

0 strong buy ratings
1 buy ratings
9 hold ratings
6 sell ratings

Ratings as of

1/27/2020

0 strong buy ratings
0 buy ratings
9 hold ratings
7 sell ratings

Ratings as of

4/26/2020

0 strong buy ratings
0 buy ratings
8 hold ratings
8 sell ratings

Ratings as of

7/25/2020

0 strong buy ratings
0 buy ratings
9 hold ratings
8 sell ratings

Ratings as of

10/23/2020

0 strong buy ratings
0 buy ratings
10 hold ratings
7 sell ratings

Ratings as of

1/21/2021

0 strong buy ratings
0 buy ratings
9 hold ratings
6 sell ratings

Ratings as of

3/22/2021

0 strong buy ratings
0 buy ratings
9 hold ratings
6 sell ratings

Ratings as of

4/21/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
4/5/2021	CIBC	Lower Price Target	Neutral	$18.50 ➝ $15.00	Low	i
2/16/2021	CIBC	Boost Price Target	Neutral	$17.00 ➝ $18.50	Low	i
2/12/2021	Canaccord Genuity	Boost Price Target	Neutral ➝ Hold	$11.00 ➝ $14.00	Low	i
2/12/2021	MKM Partners	Downgrade	Neutral ➝ Sell		Low	i
2/12/2021	Needham & Company LLC	Downgrade	Hold ➝ Underperform		Low	i
2/12/2021	Cantor Fitzgerald	Boost Price Target	Neutral	$17.00 ➝ $18.00	Low	i Rating by P. Zuanic at Cantor Fitzgerald
2/12/2021	Desjardins	Downgrade	Hold ➝ Sell		Low	i
2/8/2021	CIBC	Boost Price Target	Neutral	$15.00 ➝ $17.00	High	i
2/5/2021	Cantor Fitzgerald	Boost Price Target	Neutral	$16.00 ➝ $17.00	Low	i Rating by P. Zuanic at Cantor Fitzgerald
1/25/2021	Cantor Fitzgerald	Boost Price Target	Neutral	$12.00 ➝ $16.00	Medium	i Rating by P. Zuanic at Cantor Fitzgerald
1/4/2021	Jefferies Financial Group	Reiterated Rating	Underperform	$4.59	N/A	i
12/17/2020	BMO Capital Markets	Downgrade	Market Perform ➝ Underperform	$9.00	Low	i
11/16/2020	Atb Cap Markets	Upgrade	Underperform ➝ Sector Perform		Low	i Rating by D. Kideckel at Atb Cap Markets
11/16/2020	Jefferies Financial Group	Downgrade	Hold ➝ Underperform	$5.56 ➝ $3.75	Low	i
11/11/2020	Stifel Nicolaus	Downgrade	Hold ➝ Sell		N/A	i Rating by W. Andrew Carter at Stifel Nicolaus
11/10/2020	CIBC	Boost Price Target	Neutral	$12.00 ➝ $15.00	Low	i
11/10/2020	Canaccord Genuity	Boost Price Target	Hold	$8.50 ➝ $11.00	Low	i
11/9/2020	Atb Cap Markets	Downgrade	Sector Perform ➝ Underperform		Medium	i Rating by D. Kideckel at Atb Cap Markets
11/9/2020	Cantor Fitzgerald	Downgrade	Overweight ➝ Neutral	$13.00 ➝ $12.00	High	i Rating by P. Zuanic at Cantor Fitzgerald
10/28/2020	Stifel Nicolaus	Lower Price Target	Hold	$10.50 ➝ $3.60	Medium	i Rating by W. Andrew Carter at Stifel Nicolaus
10/27/2020	Cantor Fitzgerald	Downgrade	Overweight ➝ Neutral	$18.00 ➝ $7.00	High	i Rating by Pablo Zuanic at Cantor Fitzgerald
9/24/2020	CIBC	Lower Price Target	Neutral	$20.00 ➝ $12.00	Low	i
9/23/2020	Cowen	Reiterated Rating	Hold	$10.00	Low	i
9/23/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$17.50 ➝ $18.00	High	i Rating by Pablo Zuanic at Cantor Fitzgerald
9/23/2020	Needham & Company LLC	Reiterated Rating	Hold		High	i Rating by Matt McGinley at Needham & Company LLC
9/23/2020	Piper Sandler	Lower Price Target	Neutral	$10.00 ➝ $8.00	High	i
9/22/2020	Canaccord Genuity	Lower Price Target	Hold	$21.00 ➝ $10.00	High	i
9/21/2020	Jefferies Financial Group	Upgrade	Underperform ➝ Hold		High	i
9/9/2020	Stifel Nicolaus	Lower Price Target	Positive ➝ Hold	$16.00 ➝ $10.50	High	i Rating by W. Andrew Carter at Stifel Nicolaus
9/9/2020	Cantor Fitzgerald	Lower Price Target	Overweight	$29.00 ➝ $17.50	Low	i Rating by Pablo Zuanic at Cantor Fitzgerald
9/8/2020	Needham & Company LLC	Reiterated Rating	Hold		High	i Rating by Matt McGinley at Needham & Company LLC
9/8/2020	LADENBURG THALM/SH SH	Downgrade	Buy ➝ Neutral	$9.00	High	i
8/18/2020	CIBC	Lower Price Target	Neutral	$24.00 ➝ $20.00	Low	i
6/24/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$27.00 ➝ $29.00	Medium	i Rating by Pablo Zuanic at Cantor Fitzgerald
6/24/2020	Stifel Nicolaus	Upgrade	Sell ➝ Hold	$6.20 ➝ $17.50	Low	i
6/23/2020	Needham & Company LLC	Initiated Coverage	Hold		Low	i Rating by Matt McGinley at Needham & Company LLC
5/22/2020	CIBC	Boost Price Target	Neutral	$14.00 ➝ $24.00	Low	i
5/22/2020	Jefferies Financial Group	Downgrade	Hold ➝ Underperform	$12.00 ➝ $14.00	Medium	i Rating by Owen Bennett at Jefferies Financial Group Inc.
5/21/2020	Cantor Fitzgerald	Boost Price Target	Market Perform ➝ Overweight	$22.00 ➝ $27.00	High	i Rating by Pablo Zuanic at Cantor Fitzgerald
5/19/2020	MKM Partners	Initiated Coverage	Hold	$18.00	High	i Rating by William Kirk at MKM Partners
5/18/2020	CIBC	Reiterated Rating	Buy ➝ Market Perform	$27.00 ➝ $14.00	High	i
5/15/2020	Pi Financial	Reiterated Rating	Neutral		High	i Rating by J. Zandberg at Pi Financial
5/15/2020	Desjardins	Upgrade	Buy		High	i Rating by John Chu at Desjardins
5/15/2020	Piper Sandler	Upgrade	Underweight ➝ Neutral	$12.00 ➝ $10.00	High	i Rating by Michael Lavery at Piper Sandler
5/13/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$22.00	High	i Rating by Pablo Zuanic at Cantor Fitzgerald
5/12/2020	Eight Capital	Reiterated Rating	Hold	$11.00	High	i
4/13/2020	Cantor Fitzgerald	Lower Price Target	Overweight	$45.60 ➝ $33.00	Low	i Rating by Pablo Zuanic at Cantor Fitzgerald
4/13/2020	Needham & Company LLC	Reiterated Rating	Hold		High	i Rating by Matt McGinley at Needham & Company LLC
2/27/2020	Bryan, Garnier & Co	Downgrade	Neutral ➝ Sell		Low	i
2/25/2020	Needham & Company LLC	Initiated Coverage	Hold	$18.00	High	i
2/24/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$45.00 ➝ $45.60	Low	i Rating by Pablo Zuanic at Cantor Fitzgerald
2/24/2020	Cowen	Downgrade	Outperform ➝ Market Perform	$72.00 ➝ $30.00	Medium	i
2/16/2020	Pi Financial	Reiterated Rating	Hold	$24.00	High	i Rating by Jason Zandberg at Pi Financial
2/16/2020	CIBC	Reiterated Rating	Hold	$27.00	High	i Rating by John Zamparo at CIBC
2/14/2020	MKM Partners	Upgrade	Sell ➝ Neutral		Low	i Rating by William Kirk at MKM Partners
2/14/2020	Canaccord Genuity	Reiterated Rating	Hold	$27.00	Low	i Rating by Matt Bottomley at Canaccord Genuity
2/10/2020	CIBC	Reiterated Rating	Hold	$30.00	High	i Rating by John Zamparo at CIBC
2/7/2020	Pi Financial	Downgrade	Hold	$24.00	High	i Rating by Jason Zandberg at Pi Financial
2/7/2020	Eight Capital	Downgrade	Buy ➝ Neutral		Low	i
2/7/2020	Cantor Fitzgerald	Lower Price Target	Overweight	$60.00 ➝ $45.00	Low	i Rating by Pablo Zuanic at Cantor Fitzgerald
2/7/2020	Compass Point	Lower Price Target	Neutral	$60.00 ➝ $24.00	High	i Rating by Rommel Dionisio at Compass Point
2/7/2020	Canaccord Genuity	Downgrade	Buy ➝ Hold		Low	i Rating by Matt Bottomley at Canaccord Genuity
2/6/2020	Jefferies Financial Group	Downgrade	Hold		High	i Rating by Owen Bennett at Jefferies Financial Group Inc.
1/10/2020	Piper Jaffray Companies	Downgrade	Neutral ➝ Underweight	$36.00 ➝ $12.00	Low	i Rating by Michael Lavery at Piper Jaffray Companies
1/10/2020	Bank of America	Downgrade	Neutral ➝ Underperform	$12.00	High	i
1/10/2020	Piper Sandler	Downgrade	Overweight ➝ Neutral	$36.00 ➝ $12.00	High	i
12/31/2019	Jefferies Financial Group	Downgrade	Hold	$36.00	High	i Rating by Owen Bennett at Jefferies Financial Group Inc.
12/23/2019	MKM Partners	Reiterated Rating	Sell	$36.00 ➝ $24.00	Medium	i Rating by William Kirk at MKM Partners
12/23/2019	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$36.00	Medium	i Rating by Owen Bennett at Jefferies Financial Group Inc.
11/26/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$52.80	Low	i Rating by Pablo Zuanic at Cantor Fitzgerald
11/15/2019	MKM Partners	Downgrade	Hold	$42.00 ➝ $36.00	High	i Rating by William Kirk at MKM Partners
11/15/2019	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$61.20 ➝ $70.20	High	i Rating by P. Zuanic at Cantor Fitzgerald
11/15/2019	Piper Jaffray Companies	Lower Price Target	Neutral	$48.00 ➝ $36.00	High	i Rating by Michael Lavery at Piper Jaffray Companies
11/4/2019	Cantor Fitzgerald	Initiated Coverage	Neutral	$61.20	High	i Rating by P. Zuanic at Cantor Fitzgerald
10/22/2019	Piper Jaffray Companies	Lower Price Target	Neutral	$84.00 ➝ $48.00	Medium	i Rating by Michael Lavery at Piper Jaffray Companies
10/15/2019	Pi Financial	Set Price Target	Buy	$84.00	High	i Rating by Jason Zandberg at Pi Financial
10/11/2019	Jefferies Financial Group	Set Price Target	Buy	$84.00	Low	i Rating by Owen Bennett at Jefferies Financial Group Inc.
9/24/2019	CIBC	Initiated Coverage	Neutral	$84.00	High	i
9/20/2019	MKM Partners	Downgrade	Sell		Low	i
9/19/2019	MKM Partners	Initiated Coverage	Buy	$60.00	Medium	i
9/13/2019	Canaccord Genuity	Set Price Target	Buy	$162.00	Medium	i Rating by Matt Bottomley at Canaccord Genuity
9/13/2019	Piper Jaffray Companies	Set Price Target	Hold	$84.00	High	i Rating by Michael Lavery at Piper Jaffray Companies
9/12/2019	Compass Point	Set Price Target	Hold	$96.00	High	i Rating by Rommel Dionisio at Compass Point
9/12/2019	Stifel Nicolaus	Reiterated Rating	Hold ➝ Sell	$84.00 ➝ $60.00	High	i Rating by W. Andrew Carter at Stifel Nicolaus
8/12/2019	Piper Jaffray Companies	Initiated Coverage	Neutral ➝ Neutral	$84.00	Low	i
7/18/2019	Bank of America	Downgrade	Buy ➝ Neutral	$87.60	High	i
7/17/2019	LADENBURG THALM/SH SH	Initiated Coverage	Buy ➝ Buy	$108.00	Medium	i
7/8/2019	Compass Point	Initiated Coverage	Neutral ➝ Neutral		Medium	i
6/5/2019	Stifel Nicolaus	Initiated Coverage	Hold ➝ Hold		Medium	i
4/25/2019	Desjardins	Initiated Coverage	Buy ➝ Buy	$108.84	Low	i Rating by J. Chu at Desjardins
4/17/2019	Bank of America	Initiated Coverage	Buy ➝ Buy	$132.00	Medium	i
3/13/2019	GMP Securities	Upgrade	Hold ➝ Buy		High	i
3/5/2019	Cowen	Initiated Coverage	Outperform		High	i
2/25/2019	Jefferies Financial Group	Initiated Coverage	Buy ➝ Buy		High	i
2/21/2019	Seaport Global Securities	Initiated Coverage	Neutral ➝ Neutral		Low	i Rating by B. Hundley at Seaport Global Securities
2/12/2019	GMP Securities	Reiterated Rating	Hold	$114.00	High	i
11/10/2017	Canaccord Genuity	Reiterated Rating	Buy	$53.40	N/A	i

(Data available from 4/21/2016 forward)

Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Today's Range

Now: $7.65

$7.61

$8.37

50 Day Range

MA: $9.40

$7.79

$11.14

52 Week Range

Now: $7.65

$3.71

$19.68

Volume

9,228,826 shs

Average Volume

20,869,936 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.44

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last twelve months: Atb Cap Markets, BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, CIBC, Cowen Inc, Desjardins, Eight Capital, Jefferies Financial Group Inc., LADENBURG THALM/SH SH, MKM Partners, Needham & Company LLC, Pi Financial, Piper Sandler, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

11 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is $10.93, suggesting a possible upside of 42.8%. MKM Partners has the highest price target set, predicting ACB will reach $18.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $3.60 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 6 sell ratings and 9 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACB, but not buy more shares or sell existing shares.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

Other companies that are similar to Aurora Cannabis include Aphria, Cronos Group, Tilray, USANA Health Sciences, Sundial Growers, HEXO, ChromaDex, Canopy Rivers, MediWound, Charlie's, Natural Alternatives International, Nutra Pharma, Happiness Biotech Group, Mannatech and FitLife Brands.

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company's listed phone number is 1-855-279-4652 and its investor relations email address is [email protected] The official website for Aurora Cannabis is auroramj.com.

NYSE:ACB - Aurora Cannabis Stock Price Target and Predictions

Analyst Price Target for ACB

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

What is the current price target for Aurora Cannabis?

What is the current consensus analyst rating for Aurora Cannabis?

What other companies compete with Aurora Cannabis?

How do I contact Aurora Cannabis' investor relations team?